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INTRODUCTION
Environmental tobacco smoke (ETS), which consists of a mix-
ture of gaseous and particulate pollutants, is major indoor air 
pollution. Indoor particulate matter (PM) is also emitted from 
cooking, cleaning, and other human activities as well as from 
smoking.1,2 Indoor PM and ETS are major indoor air pollutants 
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Purpose: To investigate whether prenatal exposure to indoor fine particulate matter (PM2.5) and environmental tobacco smoke (ETS) affects suscep-
tibility to respiratory tract infections (RTIs) in infancy, to compare their effects between prenatal and postnatal exposure, and to determine whether 
genetic factors modify these environmental effects. Methods: The study population consisted of 307 birth cohort infants. A diagnosis of RTIs was 
based on parental report of a physician’s diagnosis. Indoor PM2.5 and ETS levels were measured during pregnancy and infancy. TaqMan was used for 
genotyping of nuclear factor erythroid 2-related factor (Nrf2) (rs6726395), glutathione-S-transferase-pi (GSTP) 1 (rs1695), and glutathione-S-transfer-
ase-mu (GSTM) 1. Microarrays were used for genome-wide methylation analysis. Results: Prenatal exposure to indoor PM2.5 increased the suscep-
tibility of lower RTIs (LRTIs) in infancy (adjusted odds ratio [aOR]=2.11). In terms of combined exposure to both indoor PM2.5 and ETS, prenatal expo-
sure to both pollutants increased susceptibility to LRTIs (aOR=6.56); however, this association was not found for postnatal exposure. The Nrf2 GG 
(aOR=23.69), GSTM1 null (aOR=8.18), and GSTP1 AG or GG (aOR=7.37) genotypes increased the combined LRTIs-promoting effects of prenatal 
exposure to the 2 indoor pollutants. Such effects of prenatal indoor PM2.5 and ETS exposure were not found for upper RTIs. Conclusions: Prenatal 
exposure to both indoor PM2.5 and ETS may increase susceptibility to LRTIs. This effect can be modified by polymorphisms in reactive oxygen spe-
cies-related genes.
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and may modify the effects of each other.3,4 Therefore, it is im-
portant to understand the combined effect of indoor PM and 
ETS on health and to elucidate the mechanisms involved. Al-
though there is some epidemiologic evidence on the combined 
effect of ETS and ambient air pollutants on childhood respira-
tory outcomes,5-9 results on combined exposure to indoor PM 
and ETS are limited, particularly prenatal exposure.
The prenatal period is critical in terms of the later develop-
ment of respiratory disorders in childhood because prenatal air 
pollutant exposure is associated with adverse effects on fetal 
growth10 and immune responses in early life.11-14 Prenatal and 
postnatal exposure involve different routes: prenatal air pollut-
ant exposure occurs via transplacental absorption, whereas 
postnatal exposure occurs via the respiratory route. Therefore, 
prenatal air pollutant exposure may affect health via a different 
mechanism from postnatal exposure. Based on these results, 
we hypothesized that prenatal indoor PM and ETS exposure 
compared to postnatal exposure would more severely affect the 
lower respiratory tract than the upper respiratory tract. Since 
early-childhood respiratory disorders, especially lower-respira-
tory tract infections (LRTIs), can develop into chronic respira-
tory impairment later in life,15-17 it is important to identify modi-
fiable early life determinants of adverse respiratory outcomes, 
especially those operating in the prenatal period. However, the 
impact of prenatal indoor air pollutant exposure, especially the 
interaction between indoor PM and ETS, on the susceptibility 
to LRTIs remains poorly understood.
A mechanism through which PM and ETS may lead to respi-
ratory disease is through promotion of reactive oxygen species 
(ROS).18,19 The transcription factor nuclear factor erythroid 2-re-
lated factor (Nrf2) is activated by oxidative stress and leads to 
the transcription of antioxidant genes, such as glutathione S-
transferase-pi 1 (GSTP1) and glutathione S-transferase-mu 1 
(GSTM1). Therefore, ROS-related genes and polymorphisms 
may result in different responses to PM and ETS.20 The influ-
ence of genetic variation on the association between prenatal 
exposure to indoor PM and/or ETS and susceptibility to RTIs in 
infancy remains to be studied.
Epigenetic modifications are one of the mechanisms by which 
prenatal exposures can affect disease later in life. DNA methyl-
ation is a well-characterized epigenetic modification, and there 
is evidence that it may modulate the lifelong effect of prenatal 
smoke exposure.21-23
To address these issues, a prospective birth cohort study was 
performed. The effect of prenatal indoor PM and/or ETS expo-
sure on the susceptibility of RTIs in infancy was evaluated. The 
influence of ROS-related gene polymorphisms on RTI suscepti-
bility in infancy was also assessed. Furthermore, whether pre-
natal indoor PM and ETS exposure can alter DNA methylation 
was investigated.
MATERIALS AND METHODS
Study design 
Healthy newborns (n=1,733) were recruited between Novem-
ber 2007 and December 2013. This prospective, general popu-
lation-based, birth cohort was designated as the COhort for 
Childhood Origin of Asthma and Allergic Diseases (COCOA); 
follow-up and further recruitment of this cohort is ongoing. The 
study methods have been detailed elsewhere.24,25 The indoor 
level of fine particulate matter (PM2.5) has been measured since 
2009 for the applicants. In 608 infants, the indoor levels of PM2.5 
were evaluated between 26 and 36 weeks of pregnancy. Of 
these, based on the complete PM2.5, ETS exposure, RTIs, and 
genotype data, 307 infants were finally included in the study 
(Fig. 1). Whether the 6- and 12-month-old infants had had any 
RTIs was determined by parental report of physician-diagnosed 
RTIs: “Has a doctor diagnosed RTIs in your child during the last 
6 months?” Bronchiolitis, tracheobronchitis, and/or pneumo-
nia were considered as LRTIs and common cold, sinusitis, otitis 
media, and/or croup as upper RTIs (URTIs).
Exposure assessment 
Starting in May 2009, indoor PM2.5 samples were collected by 
specialists during home visit between 26 and 36 weeks of preg-
nancy. In addition, PM2.5 samples at 6 months after birth were 
collected in the subgroup (n=75) for the applicants. PM2.5 con-
centrations were measured 3 times in the parents’ bed room by 
using a particle discriminator (Model GT-331; SIBATA Co., Ja-
pan) with a laser light-scattering optical particle counter for 5 
minutes. The mean value of 3 measurements was used for eval-
uation. The indoor PM2.5 values were log-transformed and di-
Fig. 1. Flow chart of the study population. Of infants with prenatal indoor PM2.5 
measurements (n=608), 14 met the exclusion criteria, 72 were withdrawn from 
the study, and 11 were lost to follow-up. An additional 204 infants were then 
excluded because the RTIs, prenatal ETS exposure, or genotype data were 
missing. ETS, environmental tobacco smoke; PM2.5, fine particulate matter; 
RTIs, respiratory tract infections.
Excluded n=14
Withdrawn n=72
Loss to follow up n=11
Missing ETS, RTI, and/or
genotype data n=204
Total number of children at
1 year of age (n=511)
Study population (n=307)
Total number of children at birth (n=1,733)
Children at birth with the 
PM2.5 measurement (n=608)
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chotomized to high or low by using the median value before 
being entered into the regression models. Mothers were asked 
the following questions about their ETS exposure at  home: 
“Have you been regularly exposed to passive smoking during 
your current pregnancy?”
The groups were stratified by exposure time. This led to 4 
study population groups receiving the following combination 
of prenatal/postnatal exposures: prenatal ETS/prenatal PM2.5, 
prenatal ETS/postnatal PM2.5, postnatal ETS/prenatal PM2.5, 
and postnatal ETS/postnatal PM2.5. To assess whether the 2 in-
door pollutants acted additively to increase RTI susceptibility in 
infancy, each group was divided into 4 groups according to 
their ETS exposure and whether the indoor PM2.5 levels were 
high or low.
Genotyping 
Genomic DNA was prepared from heparinized newborn um-
bilical cord blood by using a G-DEX II kit (Intron, Seoul, Korea). 
ROS-related genes were analyzed as follows. The Nrf2 
(rs6726395) and GSTP1 (rs1695) polymorphisms were geno-
typed by using a TaqMan assay (ABI, Foster City, CA, USA). The 
GSTM1 copy number was measured by real-time polymerase 
chain reaction (PCR). The genotyping method is detailed in the 
Supplemental Material.
Bisulfite conversion and genome-wide methylation array 
Nine subjects were selected from the study population to un-
dergo genome-wide methylation analysis of cord blood ge-
nomic DNA. Bisulfite conversion was performed by using the 
EZ DNA methylation kit (Zymo Research, Irvine, CA, USA) ac-
cording to the manufacturer’s instructions. The bisulfite-con-
verted genomic DNA was analyzed by using the Infinium Hu-
man Methylation 450 Beadchip (Illumina, San Diego, CA, 
USA), with >450,000 probes covering 99% of reference se-
quence genes, following the Illumina Infinium HD Methylation 
protocol. The 9 subjects and the methylation array are de-
scribed in the Supplemental Material.
Statistical analysis 
Chi-square and t tests were used to assess the significance of 
differences between the groups, as appropriate. The associa-
tions between prenatal indoor PM2.5 and/or ETS exposure and 
the incidence of RTIs at 12 months of age were analyzed by us-
ing multiple logistic regression. Adjustments were made for po-
tential confounding factors, namely, maternal age at delivery, 
maternal body mass index, maternal educational degree, gesta-
tional age, delivery mode, infant sex, and family history of aller-
gic diseases. The results are expressed as adjusted odds ratios 
(aORs) and 95% confidence intervals (CIs). All statistical analy-
ses were performed by using SPSS 18.0 software (SPSS Inc., 
Chicago, IL, USA), with a P value <0.05 considered statistically 
significant.
Ethics statement 
The study was approved by the Institutional Review Board of 
Asan Medical Center (IRB No. 2008-0616), Samsung Medical 
Center (IRB No. 2009-02-021), Yonsei University (IRB No. 
4-2008-0588), and CHA Medical Center (IRB No. 2010-010).
RESULTS
Study population characteristics  
Table 1 summarizes the characteristics of the study popula-
tion (n=307). The study population consisted of 171 boys and 
136 girls. In total, 61.6% had been prenatally exposed to mater-
nal ETS, and the mean indoor PM2.5 level during pregnancy was 
6.08±7.64 μg/m3. The frequencies of the Nrf2 (rs6726395) GG, 
GSTP1 (rs1695) AG or GG, and GSTM1 null genotypes were 
40.1%, 36.9%, and 56.7%, respectively. The distribution of the 2 
polymorphisms was in Hardy-Weinberg equilibrium. The inci-
dences of LRTIs and URTIs by the age of 12 months were 16.3% 
and 76.2%, respectively.
Table 1 also shows the characteristics of the infants who were 
not included for reasons shown in Fig. 1. There were no signifi-
cant differences between participants and non-participants, ex-
cept in gestational age and the incidence of URTIs.
Risk factors for RTIs in infancy
High PM2.5 levels during pregnancy were independent risk 
factors for LRTIs in infants (aOR=2.11; 95% CI: 1.12, 3.99) (Table 
2). However, none of the early-life environmental factors in-
creased the risk of URTIs. When we compared indoor PM2.5 lev-
els according to RTIs and exposure time, prenatal indoor PM2.5 
levels were higher in infants with LRTIs than in those without 
(mean=7.21 vs 5.71, respectively; 95% CI: 4.99, 9.44 vs 4.97, 
6.45, respectively; P=0.119,  data not shown). These differences 
were not distinct according to postnatal PM2.5 levels or the pres-
ence of URTIs.
Effects of prenatal exposure to both indoor PM2.5 and ETS on 
RTIs susceptibility in infancy
Prenatal high indoor PM2.5 and ETS exposure acted additively 
to increase the risk of LRTIs (aOR=6.56; 95% CI: 2.02, 21.24) in 
infants (Fig. 2A and Table S1). Such an additive effect was not 
replicated when examining the effects of exposure to prenatal 
PM2.5/postnatal ETS, postnatal PM2.5/prenatal ETS, and postna-
tal PM2.5/postnatal ETS on any respiratory outcomes in infants. 
In addition, such additive effects were not observed for URTIs 
risk, regardless of exposure time (Fig. 2B and Table S1).
Effect of GSTM1, GSTP1, and Nrf2 genotypes on the 
relationship between prenatal indoor PM2.5/ETS exposure and 
RTIs in infancy
Prenatal exposure to both high indoor PM2.5 and ETS in-
creased LRTIs risk in the GSTM1 null, GSTP1 AG or GG, and 
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Table 1. Characteristics of infants who were included and excluded from the study
Participants (307) Non-participants (1,426)
P value
Number Mean±SD or % Number Mean±SD or %
Sex (male, %) 171 55.7 673 51.8 0.228
Gestational age (week) 303 39.27±1.21 1,257 39.10±1.27 0.042
Maternal age at birth (year) 307 32.69±3.44 1,296 32.56±3.43 0.535
Cesarean section delivery (%) 90/269 33.5 377/1,117 33.8 0.943
Maternal body mass index (kg/m2) 307 20.53±2.24 1,352 20.66±2.63 0.369
Maternal education state 307 1,332 0.999
   ≤High school (%) 21 6.8 90 6.8
   University or college (%) 218 71.0 947 71.1
   Graduate school (%) 68 22.2 295 22.2
Parental history of allergic disease (%) 178/295 60.3 615/1,085 56.7 0.288
Maternal ETS exposure during pregnancy (%) 189/307 61.6 668/1,084 61.6 1.000
Infantile ETS exposure at 1 year (%) 75/241 31.1 196/600 32.7 0.684
PM2.5 during pregnancy (μg/m3) 307 6.08±7.64 307 5.70±4.97 0.461
PM2.5 at 6 months of age (μg/m3) 75 5.11±7.05 245 5.40±5.33 0.699
Nrf2 GG genotype (%) 123/307 40.1 351/913 38.4 0.636
GSTP1 AG or GG genotype (%) 113/306 36.9 295/919 32.1 0.124
GSTM1 null genotype (%) 173/305 56.7 490/911 53.8 0.388
Incidence of LRTIs* at 1 year (%) 49/300 16.3 111/637 17.4 0.917
Incidence of URTIs† at 1 year (%) 234/307 76.2 450/668 67.4 0.005
*Lower respiratory tract infections: tracheobronchitis, pneumonia, and bronchiolitis; †Upper respiratory tract infections: common cold, sinusitis, otitis media, and 
croup.
ETS, environmental tobacco smoke; GSTM1, glutathione S-transferase-mu 1; GSTP1, glutathione S-transferase-pi 1; Nrf2, nuclear factor erythroid 2-related factor; 
PM2.5, fine particulate matter; LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections.
Table 2. Risk factors for respiratory tract infections in infancy
LRTIs URTIs
aOR* 95% CI P value aOR* 95% CI P value
Sex (male) 1.53 (1.01, 2.31) 0.046 1.04 (0.75, 1.45) 0.799
Parental history of allergic disease 0.87 (0.58, 1.30) 0.500 0.97 (0.70, 1.35) 0.863
Gestational age 0.94 (0.80, 1.10) 0.450 0.94 (0.83, 1.08) 0.393
Cesarean section delivery 1.14 (0.74, 1.75) 0.550 0.75 (0.53, 1.06) 0.098
Higher maternal education state 1.08 (0.74, 1.58) 0.683 1.12 (0.82, 1.54) 0.468
Maternal age at birth 0.99 (0.93, 1.05) 0.713 1.06 (1.01, 1.11) 0.019
Maternal body mass index 1.04 (0.96, 1.12) 0.363 0.94 (0.88, 1.01) 0.078
Higher PM2.5 during pregnancy 2.11 (1.12, 3.99) 0.021 1.23 (0.71, 2.15) 0.463
Higher PM2.5 at 6 months of age 0.89 (0.37, 2.18) 0.801 1.00 (0.52, 1.94) 0.999
Maternal ETS exposure during pregnancy 1.33 (0.87, 2.04) 0.193 1.15 (0.82, 1.62) 0.414
Infantile ETS exposure at 1 year 0.87 (0.53, 1.42) 0.576 0.79 (0.53, 1.17) 0.241
Nrf2 GG genotype 1.27 (0.82, 1.97) 0.290 0.55 (0.39, 0.78) 0.001
GSTP1 AG or GG genotype 1.53 (0.98, 2.38) 0.062 0.89 (0.62, 1.28) 0.523
GSTM1 null genotype 1.69 (1.07, 2.67) 0.024 0.91 (0.64, 1.30) 0.612
*Odds ratios were adjusted for maternal age, maternal body mass index, maternal educational state, infant sex, gestational age, delivery mode, and family history 
of allergy.
ETS, environmental tobacco smoke; GSTM1, glutathione S-transferase-mu 1; GSTP1, glutathione S-transferase-pi 1; Nrf2, nuclear factor erythroid 2-related factor; 
PM2.5, fine particulate matter; LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections.
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Fig. 2. Effect of combined exposure to both PM2.5 and ETS according to exposure time on susceptibility to (A) lower and (B) upper respiratory tract infections in infan-
cy. The groups were stratified by exposure time: (a) prenatal PM2.5/prenatal ETS; (b) prenatal PM2.5/postnatal ETS; (c) postnatal PM2.5/prenatal ETS; and (d) postnatal 
PM2.5/postnatal ETS. Prenatal high indoor PM2.5 and ETS exposure acted additively to increase the risk of lower respiratory tract infections. *Adjustments for mater-
nal age at delivery, maternal body mass index, maternal educational degree, gestational age, delivery mode, infant sex, and family history of allergy. ETS, environ-
mental tobacco smoke; PM2.5, fine particulate matter.
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Nrf2 GG genotypes (aOR=8.18, 95% CI: 1.53, 43.72; aOR=7.37, 
95% CI: 1.12, 48.66; and aOR=23.69, 95% CI: 2.13, 263.07, re-
spectively). Such gene–environment interactions were not ob-
served for URTIs (Tables 3-5). 
Relationship between DNA methylation patterns and prenatal 
indoor PM2.5/ETS exposure
Prenatal indoor PM2.5/ETS exposure was associated specifi-
cally with 15 CpG sites, 6 of which were located in intergenic re-
gions. Of the remaining 9 CpG sites, 5 were hypomethylated 
and 4 were hypermethylated by PM2.5/ETS exposure. This anal-
ysis is described in the Supplemental Material.
DISCUSSION
The present study showed that indoor PM2.5 and ETS expo-
sure may have an effect on RTIs in infants and revealed that the 
adverse effect may depend on the timing of the exposure. The 
Table 3. Influence of the glutathione S-transferase-mu 1 (GSTM1) copy number variation on the results of prenatal exposure to both PM2.5 and ETS
GSTM1 present GSTM1 null GSTM1 present GSTM1 null
LRTIs LRTIs URTIs URTIs
No 
(n=112)
Yes
(n=17)
No 
(n=137)
Yes
(n=32)
No 
(n=36)
Yes
(n=87)
No
(n=37)
Yes
(n=150)
n n aOR*(95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI)
PM2.5 (Low) 29 2 1.00 34 3 1.00 6 26 1.00 10 27 1.00
ETS (No)
PM2.5 (Low) 37 7 1.68 45 12 4.52 11 33 0.51 12 48 2.02
ETS (Yes) (0.24, 11.79) (0.87, 23.60) (0.14, 1.83) (0.68, 6.01)
PM2.5 (High) 13 2 2.26 28 4 1.65 4 12 0.69 9 25 1.17
ETS (No) (0.26, 19.36) (0.24, 11.29) (0.13, 3.76) (0.38, 3.57)
PM2.5 (High) 33 6 3.75 30 13 8.18 9 32 0.57 11 33 1.86
ETS (Yes) (0.52, 27.10) (1.53, 43.72) (0.14, 2.35) (0.60, 5.75)
*Odds ratios were adjusted for maternal age, maternal body mass index, maternal educational state, infant sex, gestational age, delivery mode, and family history 
of allergy.
aOR, adjusted odds ratio; CI, confidence interval; ETS, environmental tobacco smoke; PM2.5, fine particulate matter; GSTM1, glutathione S-transferase-mu 1; LRTIs, 
lower respiratory tract infections; URTIs, upper respiratory tract infections.
Table 4. Influence of the glutathione S-transferase-pi 1 (GSTP1) (rs1695) polymorphism on the results of prenatal exposure to both PM2.5 and ETS
GSTP1 AA GSTP1  AG+GG GSTP1 AA GSTP1  AG+GG
LRTIs LRTIs URTIs URTIs
No 
(n=159)
Yes
(n=29)
No 
(n=91)
Yes
(n=20)
No 
(n=45)
Yes
(n=151)
No
(n=27)
Yes
(n=86)
n n aOR*(95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI)
PM2.5 (Low) 38 3 1.00 25 2 1.00 9 33 1.00 7 20 1.00
ETS (No)
PM2.5 (Low) 59 12 3.57 24 7 4.04 15 58 1.14 9 23 1.18
ETS (Yes) (0.66, 19.17) (0.62, 26.30) (0.41, 3.15) (0.29, 4.71)
PM2.5 (High) 26 3 2.82 14 3 1.70 9 23 0.75 3 14 1.43
ETS (No) (0.40, 19.77) (0.19, 15.01) (0.24, 2.34) (0.28, 7.30)
PM2.5 (High) 36 11 6.32 28 8 7.37 12 37 0.83 8 29 1.80
ETS (Yes) (1.18, 33.94) (1.12, 48.66) (0.28, 2.43) (0.41, 7.97)
*Odds ratios were adjusted for maternal age, maternal body mass index, maternal educational state, infant sex, gestational age, delivery mode, and family history 
of allergy.
aOR, adjusted odds ratio; CI, confidence interval; ETS, environmental tobacco smoke; PM2.5, fine particulate matter; GSTP1, glutathione S-transferase-pi 1; LRTIs, 
lower respiratory tract infections; URTIs, upper respiratory tract infections.
Prenatal Indoor Pollutants and Respiratory Infections
Allergy Asthma Immunol Res. 2015 November;7(6):573-582. http://dx.doi.org/10.4168/aair.2015.7.6.573
AAIR
579http://e-aair.org
ability of indoor PM2.5 and/or ETS to increase susceptibility to 
LRTIs appeared to be stronger when the exposure occurred 
during the prenatal period rather than the postnatal period. 
This study also showed that the genetic polymorphisms 
GSTM1, GSTP1 (rs1695), and/or Nrf2 (rs6726395) were further 
associated with the increased susceptibility of LRTIs in indoor 
PM2.5/ETS-exposed infants. Thus, the susceptibility of LRTIs in 
infancy may be shaped by gene-environment interactions be-
tween ROS-related genes and prenatal indoor PM2.5/ETS expo-
sure. To our knowledge, this is the first study to evaluate the as-
sociation between combined exposure to indoor PM2.5/ETS 
and infants’ susceptibility to LRTIs that is associated with expo-
sure time and genetic susceptibility.
Most people spend as much as 90% of their time indoors, espe-
cially pregnant women and infants. Chronic exposure to indoor 
pollutants at home or school can increase air pollutant inhala-
tion and significantly impact health.26,27 The interaction between 
PM and ETS, the most important indoor air pollutants, modify 
their individual harmful effects on respiratory outcomes.7,8 How-
ever, studies about the indoor PM concentration that would 
have an adverse health outcome and an interaction between 
PM and ETS, especially prenatal exposure, are scarce. Our study 
revealed the effect of indoor PM2.5 even in the low concentration 
and the additive effect of indoor PM2.5/ETS exposure during the 
prenatal period on the development of LRTIs in infancy.
The fetal period is critical for lung and immune development. 
Although some epidemiologic studies showed that prenatal 
PM or ETS exposure increases the risk of wheezing, asthma, 
and respiratory infections,28-31 studies comparing the effect ac-
cording to exposure time are limited. A few studies revealed 
that prenatal exposure has a stronger effect on respiratory out-
comes than postnatal exposure.32-34 We also found its stronger 
associations with combined exposures to indoor PM2.5/ETS 
during the prenatal period than the postnatal period. However, 
this result must be interpreted with caution because it is diffi-
cult to clearly separate exposure periods.
Air pollutants and tobacco smoke exert their harmful effects 
on health by inducing oxidative stress in exposed cells and tis-
sues.18,19 Air pollutants can be directly absorbed to the fetal cir-
culation and produce ROS, ultimately inducing inflammatory 
and oxidative stress responses in the fetal lung.35 The fetus can 
also be affected indirectly by the oxidative stress and inflamma-
tory cytokine production induced in the placenta by the pollut-
ants.36 Of particular interest in this regard are several intracellu-
lar antioxidant enzymes, including GSTM1 and GSTP1, which 
defend the airway epithelium from damage caused by oxidants 
and inflammation. These enzymes are regulated by the tran-
scription factor Nrf2, which translocates to the nucleus after ox-
idative stress induction.37 These enzymes in respiratory disease 
pathogenesis after pollutant exposure is provided by results 
showing that children with the GSTM1 null genotype are more 
likely to develop asthma and wheezing after prenatal ETS expo-
sure than children with the GSTM1 present genotype.20 Similar-
ly, our study showed that while both prenatal indoor PM2.5 and 
ETS exposure greatly increased the incidence of LRTIs in in-
fants, this effect was particularly marked in the infants with the 
GSTM1 null, GSTP1 (rs1695)  AG or GG, or Nrf2 (rs6726395) GG 
genotypes.
ROS reacts with lipids, proteins, and DNA, resulting in cell 
membrane damage, alteration of gene and protein expression, 
Table 5. Influence of the nuclear factor erythroid 2-related factor (Nrf2) (rs6726395) on the results of prenatal exposure to both PM2.5 and ETS
Nrf2  GG Nrf2 GA+AA Nrf2  GG Nrf2 GA+AA
LRTIs LRTIs URTIs URTIs
No 
(n=98)
Yes
(n=22)
No 
(n=153)
Yes
(n=27)
No 
(n=36)
Yes
(n=87)
No
(n=37)
Yes
(n=150)
n n aOR*(95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI) n n
aOR*
 (95% CI)
PM2.5 (Low) 31 2 1.00 32 3 1.00 9 24 1.00 7 29 1.00
ETS (No)
PM2.5 (Low) 26 10 9.66 57 9 1.19 9 27 1.20 15 54 1.09
ETS (Yes) (0.99, 94.03) (0.27, 5.18) (0.36, 3.94) (0.34, 3.53)
PM2.5 (High) 20 2 4.27 21 4 1.19 9 15 0.66 4 22 1.65
ETS (No) (0.31, 58.04) (0.19, 7.31) (0.19, 2.29) (0.36, 7.52)
PM2.5 (High) 21 8 23.69 43 11 2.82 9 21 0.81 11 45 1.75
ETS (Yes) (2.13, 263.07) (0.65, 12.31) (0.23, 2.94) (0.48, 6.42)
*Odds ratios were adjusted for maternal age, maternal body mass index, maternal educational state, infant sex, gestational age, delivery mode, and family history 
of allergy.
aOR, adjusted odds ratio; CI, confidence interval; ETS, environmental tobacco smoke; PM2.5, fine particulate matter; Nrf2, nuclear factor erythroid 2-related factor; 
LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections.
Yang et al.
Allergy Asthma Immunol Res. 2015 November;7(6):573-582. http://dx.doi.org/10.4168/aair.2015.7.6.573
Volume 7, Number 6, November 2015
580 http://e-aair.org
and even cell death.18,37 Secondary mediators generated by oxi-
dant reactions with lipids, proteins, and other biomolecules 
contribute to the toxic effects of pollutants. Oxidative stress also 
induces MAP kinase and NF-κB activation, which may ulti-
mately produce a variety of proinflammatory mediators. Proin-
flammatory mediators from the airway epithelium play a criti-
cal role in the pathogenesis of several pulmonary diseases. Pre-
vious experimental studies supported the association between 
air pollutants and oxidative stress by demonstrating that anti-
oxidant pretreatment attenuates oxidative stress and airway ep-
ithelial cell injury induced by air pollutants.38-40
Prenatal exposure to environmental factors may affect disease 
susceptibility later in life by inducing epigenetic changes. A 
cross-sectional study of children under 18 years of age revealed 
that air pollutants and ETS both associate with significantly in-
creased DNA methylation and decreased transcription of inter-
feron gamma (IFN-γ) in T-effector cells and forkhead box tran-
scription factor 3 (Foxp3) in T-regulatory cells.41 Interestingly, 
GSTM1 and GSTP1 polymorphisms alter the ability of prenatal 
tobacco smoke exposure to induce global DNA methylation.21 
Although the sample size in our experiment was too small to 
make firm conclusions, our data suggest that the ability of pre-
natal indoor PM2.5 and ETS exposure to promote LRTIs in in-
fancy may be due to DNA methylation alterations; the 9 CpG 
sites whose methylation was significantly altered by PM2.5/ETS 
exposure were in subjects with LRTIs (Table S2 and Fig. S1). 
Further studies on this issue are required.
This study has several limitations. First, it was not possible to 
clearly distinguish between the effects of prenatal and postna-
tal exposure or exposure that persisted during both the pre- 
and postnatal periods. Further studies on the effect of indoor 
PM and ETS exposure during specific prenatal and postnatal 
periods may help identify the mechanisms involved. Second, 
the RTIs and ETS data were derived from questionnaires, and 
the indoor PM2.5 levels were measured only 1 day between 26 
and 36 weeks of pregnancy and at 6 months of age. Therefore, 
an information bias could not be excluded. Although question-
naires may misclassify ETS exposure, previous studies have 
shown a fairly good correlation between self-reported ETS ex-
posure and biomarkers of ETS exposure.5,42-44 Future studies 
may gain greater sensitivity by using more objective and precise 
measures of RTIs, and smoke and indoor PM exposure. The 
third limitation is the relatively small study population, which is 
because the indoor PM2.5 measurements started later in the 
COCOA study, and these data were thus only available for 
about one-third of the whole COCOA cohort. However, it is un-
likely that the addition of indoor PM2.5 measurements to the 
protocol introduced a selection bias because the study partici-
pants and non-participants did not differ significantly in terms 
of their characteristics. An increase in the sample size would be 
likely to lead to more consistent and significant data. The fourth 
limitation is that we only selected 1 polymorphism from each 
gene. However, these polymorphisms have been shown in sev-
eral studies to contribute to asthma susceptibility.20,45-47
An important strength of our study is its prospective design: 
the indoor PM2.5 and ETS exposure data and the data on many 
potential confounders were collected before the children were 
born. This is likely to have markedly reduced the study bias. An 
additional strength is that the PM2.5 measurement was per-
formed at home. This direct measurement of residential indoor 
PM2.5 probably estimates the actual exposure levels more accu-
rately than other indirect methods. Finally, we investigated ge-
notypic data for GSTM1, GSTP1, and Nrf2 to determine gene–
environment interactions between both PM2.5/ETS exposure 
and LRTIs. These results imply that air pollutant exposure 
should be reduced, especially in genetically susceptible infants, 
and support a mechanism for oxidative stress in inducing ad-
verse respiratory outcomes by air pollutants.
It should be noted that there was an important difference be-
tween previous studies and ours, namely, that maternal ETS ex-
posure was considered in our study. It was not possible to eval-
uate the effect of maternal active smoking because the active 
smoking rate of Korean women is low: only 11.4% of the CO-
COA cohort mothers had smoked before their pregnancy, of 
whom only 1 continued to smoke during pregnancy. Thus, ma-
ternal ETS exposure was more likely to be an important source 
of pollutant exposure in our cohort than maternal smoking.
CONCLUSIONS
Indoor PM2.5 and ETS exposure increases susceptibility to LR-
TIs in infants. This effect was particularly marked when the ex-
posure occurred in the prenatal period. Moreover, the effect 
was modified by ROS-related gene polymorphisms. Along with 
studies suggesting that acute LRTIs in early life is associated 
with a long-standing susceptibility to all forms of lung disease, 
including asthma,15-17 our study highlights the importance of 
health intervention strategies that focus on the indoor environ-
ment in the prenatal period. Additional analyses of genetic and 
epigenetic variants may help individualize such strategies. Fur-
ther studies of gene–environment interactions and epigenetic 
mechanisms that shape the effect of air pollutants on suscepti-
bility to LRTIs and chronic lung diseases are warranted, along 
with studies assessing the association between LRTIs in infancy 
and the development of chronic lung diseases, such as asthma.
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